InspireMD to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference

InspireMD, Inc. (Nasdaq: NSPR), an innovator in the field of carotid stenting, has announced its participation in the Piper Sandler 37th Annual Healthcare Conference. The event is scheduled for Wednesday, December 3rd, at 12:30 PM Eastern Time. This fireside discussion will provide a platform for the company to showcase its proprietary CGuard® Prime carotid stent system, which aims to significantly reduce the risk of stroke for patients.

InspireMD focuses on leveraging its unique MicroNet™ mesh technology to enhance the efficacy and safety of carotid stenting procedures, aspiring to set a new industry standard. The company is committed to demonstrating not only excellent short-term outcomes but also long-term stroke-free results, positioning its products as a preferred choice among healthcare providers.

Investors interested in the discussion can access a live audio webcast through the “Investor Calendar” section of InspireMD’s website, where a replay will also be made available post-event.

As the company continues to navigate the competitive landscape of medical devices, its focus on innovation and patient outcomes aligns with broader trends in healthcare, emphasizing the importance of effective solutions for stroke prevention. InspireMD's common stock is publicly traded on the Nasdaq under the ticker symbol NSPR, and the company actively shares relevant updates and insights with its investors through its website.

For additional inquiries or investor information, Webb Campbell from Gilmartin Group LLC can be reached at webb@gilmartinir.com or through InspireMD’s dedicated investor relations contact. With its upcoming participation in the healthcare conference, InspireMD is poised to engage with potential investors and stakeholders, furthering its mission to enhance patient care in the field of carotid artery disease.

InspireMD, Inc. (Nasdaq: NSPR), a noteworthy player in the cardiology sector, is set to participate in the Piper Sandler 37th Annual Healthcare Conference on December 3, 2025. This event presents a significant opportunity for the company to share insights into its innovative CGuard® Prime carotid stent system, specifically designed to prevent strokes. Investors should take note of this upcoming presentation, as it could influence stock performance and provide valuable updates on the company’s strategic direction.

InspireMD’s proprietary MicroNet™ mesh technology positions it to potentially transform the carotid stenting market. An emphasis on enhanced acute results and long-term outcomes may attract interest from both institutional and individual investors, especially as the healthcare sector increasingly prioritizes effective and safer solutions for chronic conditions. The company's focus on stroke prevention aligns well with current healthcare trends towards preventive solutions, which could boost its market relevance.

The timing of this presentation is crucial; discussions around innovative medical technologies can galvanize investor interest, particularly if the executives convey strong growth potential and market penetration strategies. Given the current volatility in the healthcare sector, analysts should closely monitor InspireMD’s performance metrics leading into and following the conference. Strategic updates, partnerships, or data supporting the efficacy of their technology shared during this conference can act as catalysts for stock price movements.

For investors contemplating adding InspireMD to their portfolios, it is advisable to approach with a keen awareness of market conditions and the company's financial health. The accessibility of the live stream allows investors to evaluate the management's vision firsthand. Long-term investors may find that this event provides critical insights into InspireMD’s trajectory, potentially reinforcing their investment thesis regarding technological adoption in the carotid stenting domain.